article thumbnail

STAT+: The race to build better CRISPR delivery vehicles is heating up

STAT

In the pipeline are treatments that attempt to accomplish this by borrowing stealthing technologies from other fields, like gene therapy’s viral vector workhorse, AAV , or the lipid nanoparticles that coat RNA-interfering drugs and mRNA vaccines.

Packaging 360
article thumbnail

STAT+: Pharmalittle: Weight-loss drug ads pose new oversight challenge; will the new Bayer CEO split the company?

STAT

They may involve infusions of a gene packaged inside the shell of a virus, which can lead to potential immune complications and can require close monitoring of patients. Promising therapies for some diseases are administered through lumbar punctures, which are not a routine part of a doctor’s daily practice.

Packaging 245
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA declines Eli Lilly’s bowel disease drug over manufacturing issues

Pharmafile

However, concerns weren’t expressed over the clinical data package, safety or label for the medicine. Mirikizumab was hoped to become a new drug treatment for ulcerative colitis (UC), a condition where abnormal reactions in the immune system cause inflammation in the inner lining of the colon. read more

Packaging 119
article thumbnail

New antibody could be promising cancer treatment

World Pharma News

Researchers have developed a unique type of antibody that both targets and delivers a drug package via the antibody itself, while simultaneously activating the immune system ("3-in-1 design") for personalised immunotherapy treatments. The study has been published in Nature Communications.

article thumbnail

CanSinoBIO developed a highly effective COVID vaccine with an inhalant version

pharmaphorum

It then elicits an immune response against that spike protein. Morgon says CanSinoBIO produced an inhalant version of Convidencia because an immune response called mucosal immunity is triggered in addition to the circulating antibodies and the T cell response. There’s no additional replication in the person.

Vaccines 138
article thumbnail

Mitigating fill, finish and CCI challenges for injectables

Express Pharma

In the case of parenteral drugs, CCI aims to avoid adulteration of the drugs packaged in vials, syringes, and cartridges. Even though these types of packaging systems are sealed in a hermetic manner, there are still many risks to mitigate. Vials, cartridges, and syringes are often packaged one of two ways. micron filter.

article thumbnail

What Are Biopharmaceuticals?

Pharma Packaging Solutions

Whole blood, organ and tissue transplants, breast milk, antibodies for passive immunity, fecal microbiota, human reproductive cells, and stem-cell therapy are all examples of this type of biologic. As biopharma technology progresses, becoming both more prevalent and available, the need for high-quality biopharma packaging increases.